These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7882553)

  • 41. Synovial fluid induced nuclear factor-kappaB DNA binding in a monocytic cell line.
    Lehmann T; Nguyen LQ; Handel ML
    J Rheumatol; 2000 Dec; 27(12):2769-76. PubMed ID: 11128662
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nuclear factor kappaB/p50 activates an element in the distal matrix metalloproteinase 1 promoter in interleukin-1beta-stimulated synovial fibroblasts.
    Vincenti MP; Coon CI; Brinckerhoff CE
    Arthritis Rheum; 1998 Nov; 41(11):1987-94. PubMed ID: 9811054
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sublethal levels of oxidative stress stimulate transcriptional activation of c-jun and suppress IL-2 promoter activation in Jurkat T cells.
    Beiqing L; Chen M; Whisler RL
    J Immunol; 1996 Jul; 157(1):160-9. PubMed ID: 8683110
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular mechanism of NFAT family proteins for differential regulation of the IL-2 and TNF-alpha promoters.
    Oum JH; Han J; Myung H; Hleb M; Sharma S; Park J
    Mol Cells; 2002 Feb; 13(1):77-84. PubMed ID: 11911478
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of NF(P), the nuclear factor that interacts with the regulatory P sequence (5'-CGAAAATTTCC-3') of the human interleukin-4 gene: relationship to NF-kappa B and NF-AT.
    Matsuda I; Masuda ES; Tsuboi A; Behnam S; Arai N; Arai K
    Biochem Biophys Res Commun; 1994 Mar; 199(2):439-46. PubMed ID: 8135784
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transcriptional control of IL-2 and IL-4 in T cells of young and old mice.
    Albright JW; Zúñiga-Pflücker JC; Albright JF
    Cell Immunol; 1995 Sep; 164(2):170-5. PubMed ID: 7656324
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Natural killer cells in connective tissue disorders.
    Sibbitt WL; Bankhurst AD
    Clin Rheum Dis; 1985 Dec; 11(3):507-21. PubMed ID: 3907953
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased expression of c-rel, from the NF-kappaB/Rel family, in T cells from patients with systemic lupus erythematosus.
    Burgos P; Metz C; Bull P; Pincheira R; Massardo L; Errázuriz C; Bono MR; Jacobelli S; González A
    J Rheumatol; 2000 Jan; 27(1):116-27. PubMed ID: 10648027
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Th2-specific protein/DNA interactions at the proximal nuclear factor-AT site contribute to the functional activity of the human IL-4 promoter.
    Li-Weber M; Salgame P; Hu C; Davydov IV; Laur O; Klevenz S; Krammer PH
    J Immunol; 1998 Aug; 161(3):1380-9. PubMed ID: 9686601
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of NF-kappa B nuclear activity in peripheral blood mononuclear cells: role of CD28 antigen.
    Romano MF; Bisogni R; Lamberti A; Turco MC; Petrella A; Tassone P; Van Lier R; Formisano S; Venuta S
    Cell Immunol; 1994 Jul; 156(2):371-7. PubMed ID: 8025954
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo anergized CD4+ T cells express perturbed AP-1 and NF-kappa B transcription factors.
    Sundstedt A; Sigvardsson M; Leanderson T; Hedlund G; Kalland T; Dohlsten M
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):979-84. PubMed ID: 8577772
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Silencer and enhancer regions in the human CD95 (Fas/APO-1) gene with sequence similarity to the granulocyte-macrophage colony-stimulating factor promoter: binding of single strand-specific silencer factors and AP-1 and NF-AT-like enhancer factors.
    Rudert F; Lindridge E; Lasham A; Wang Y; Grandison P; Watson J
    DNA Cell Biol; 1998 Dec; 17(12):991-1002. PubMed ID: 9881666
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IL-1 induces collagenase-3 (MMP-13) promoter activity in stably transfected chondrocytic cells: requirement for Runx-2 and activation by p38 MAPK and JNK pathways.
    Mengshol JA; Vincenti MP; Brinckerhoff CE
    Nucleic Acids Res; 2001 Nov; 29(21):4361-72. PubMed ID: 11691923
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. Differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease.
    Skriner K; Sommergruber WH; Tremmel V; Fischer I; Barta A; Smolen JS; Steiner G
    J Clin Invest; 1997 Jul; 100(1):127-35. PubMed ID: 9202064
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The architecture of the interleukin-2 promoter: a reflection of T lymphocyte activation.
    Serfling E; Avots A; Neumann M
    Biochim Biophys Acta; 1995 Sep; 1263(3):181-200. PubMed ID: 7548205
    [No Abstract]   [Full Text] [Related]  

  • 56. Adverse childhood experience and rheumatic diseases.
    Luiz APL; Antico HA; Skare TL; Boldt ABW; Nisihara R
    Clin Rheumatol; 2018 Oct; 37(10):2863-2867. PubMed ID: 29992393
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NFkappaB and AP-1 DNA binding activity in patients with multiple sclerosis.
    Flores N; Durán C; Blasco MR; Puerta C; Dorado B; García-Merino A; Ballester S
    J Neuroimmunol; 2003 Feb; 135(1-2):141-7. PubMed ID: 12576234
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transcription factors: important tools and targets for molecular medicine.
    Scheidereit C
    J Mol Med (Berl); 1996 Dec; 74(12):707-9. PubMed ID: 8974014
    [No Abstract]   [Full Text] [Related]  

  • 59. The DNA-binding activities of NF-AT and AP-1 can predict levels of immunosuppression of kidney transplant recipients.
    Akioka K; Nakajima H; Fujiwara I; Matsuda T; Yoshimura N; Arakawa K; Ohmori Y; Tsujimura A; Hashimoto-Gotoh T; Oka T
    Transplant Proc; 1997 Sep; 29(6):2621-3. PubMed ID: 9290766
    [No Abstract]   [Full Text] [Related]  

  • 60. RGC32 Promotes Bleomycin-Induced Systemic Sclerosis in a Murine Disease Model by Modulating Classically Activated Macrophage Function.
    Sun C; Chen SY
    J Immunol; 2018 Apr; 200(8):2777-2785. PubMed ID: 29507108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.